Specific alterations of sphingolipid metabolism identified in EpCAM-positive cells isolated from human colon tumors

Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158742. doi: 10.1016/j.bbalip.2020.158742. Epub 2020 May 21.

¹ Department of Chemistry and Toxicology, Veterinary Research Institute, Brno, Czech Republic.
² Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, Czech Republic.
³ Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
⁴ University Hospital, Olomouc, Czech Republic.
⁵ Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
⁶ Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Electronic address: vondracek@ibp.cz.
⁷ Department of Chemistry and Toxicology, Veterinary Research Institute, Brno, Czech Republic. Electronic address: machala@vri.cz.

No abstract available

Keywords: B4GALTs; Colon adenocarcinoma; EPCAM-positive cells; Lactosylceramide; Sphingolipid metabolism.

Publication types